NASDAQ:BIOC

Biocept, Inc Earning Date

USA |NASDAQ |USD

BIOC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 10, 2021 Sep 2021 $0.06 $-0.51 $-0.43
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 10, 2021 Sep 2021 $16.07M $12.05M $6.59M

Biocept, Inc's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.

BIOC Earnings Date & History Chart

BIOC Earnings & Revenue Forecast

BIOC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.19 $-0.22 $-0.17
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.08 $-0.09 $-0.08
Dec 2022 2 $-1.08 $-1.12 $-1.04

BIOC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.17 $-0.17 $-0.45
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.08 $-0.08 $-0.82
Dec 2022 0 / 0 $-1.12 $-1.12 $-1.26

BIOC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $9.92M $8.40M $11.44M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $56.45M $55.10M $57.81M
Dec 2022 2 $32.28M $32.00M $32.57M

BIOC Earnings Date & Revenue History

BIOC Earnings History

|
Show More
Show More

BIOC Revenue History

|
Show More
Show More

Biocept, Inc Next Earnings Date & Report

BIOC Next Earnings Date & Report Preview: Sep 2021 (FQ)

BIOC's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 2 analysts, the average EPS estimation for Biocept, Inc's next quarterly earnings is $0.06, with a low EPS estimation of $0.04, and a high estimation of $0.09.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.04, the last 2 month trend is $0.04, and the 3 month trend is $-0.39.

Based on 2 analysts, the average revenue estimation is $16.07M, with a low revenue estimation of $15.24M, and a high estimation of $16.90M.

Biocept, Inc Previous Earnings Dates & Reports

BIOC Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Biocept, Inc's previous earnings date was Aug 16, 2021 for its fiscal quarter ended Jun 30, 2021.

BIOC's earnings per share (EPS) was $-0.51, missing the consensus analysts forecast of $-0.16 by -218.75%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -368.42%, and lower than the same period a year before (Jun 2020) by 2.00%.

Revenues were $12.05M, down by -32.15% from the previous quarter , and up by 1213.08% from the same period last year.

The company reported a net income of $-1.83M.

Free cash flow for the quarter was $1.85M , compared to $131.62K last quarter and $-6.71M a year before.

BIOC ended the quarter with $13.13M in total debt, an increase of 2.66% compared to the previous quarter, and an increase of 319.82% compared to the same quarter a year before.

BIOC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Biocept, Inc's previous annual earnings date was Mar 29, 2021 for its fiscal year ended Dec 31, 2020.

BIOC's earnings per share (EPS) was $-1.89, beating the consensus analysts forecast of $-2.11 by -10.43% , and higher than the previous year's EPS (Dec 2019) by -86.88%.

Revenues were $27.46M, better than the forecast of $21.22M by 29.41%, and up by 396.72% from previous year's revenue.

The company reported a net income of $-17.81M.

Biocept, Inc reported a free cash flow of $-20.65M for its fiscal year, compared to $-23.78M a year ago.

The company ended the fiscal year with $10.77M in total debt, an increase of 323.98% compared to the previous year.